These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16472101)

  • 21. Nano-based drug delivery optimization for tuberculosis treatment: A review.
    Dahanayake MH; Jayasundera ACA
    J Microbiol Methods; 2021 Feb; 181():106127. PubMed ID: 33359155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Present status of nanoparticle research for treatment of tuberculosis.
    Shegokar R; Al Shaal L; Mitri K
    J Pharm Pharm Sci; 2011; 14(1):100-16. PubMed ID: 21501557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitubercular inhaled therapy: opportunities, progress and challenges.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2005 Apr; 55(4):430-5. PubMed ID: 15761077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respirable nanocarriers as a promising strategy for antitubercular drug delivery.
    Mehanna MM; Mohyeldin SM; Elgindy NA
    J Control Release; 2014 Aug; 187():183-97. PubMed ID: 24878180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained release of isoniazid from polylactide microspheres prepared using solid/oil drug loading method for tuberculosis treatment.
    Zhang L; Li Y; Zhang Y; Zhu C
    Sci China Life Sci; 2016 Jul; 59(7):724-31. PubMed ID: 27278371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.
    Gelperina S; Kisich K; Iseman MD; Heifets L
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1487-90. PubMed ID: 16151040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured drug delivery for better management of tuberculosis.
    Kaur IP; Singh H
    J Control Release; 2014 Jun; 184():36-50. PubMed ID: 24732260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.
    Pandey R; Khuller GK
    J Antimicrob Chemother; 2004 Apr; 53(4):635-40. PubMed ID: 14998985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nanoparticles as drug delivery system for antituberculous drugs].
    Sanzhakov MA; Ipatova OM; Torkhovskaia TI; Prozorovskiĭ VN; Tikhonova EG; Druzhilovskaia OS; Medvedeva NV
    Vestn Ross Akad Med Nauk; 2013; (8):37-44. PubMed ID: 24340644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis.
    Garg T; Rath G; Murthy RR; Gupta UD; Vatsala PG; Goyal AK
    Curr Pharm Des; 2015; 21(22):3076-89. PubMed ID: 26027577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug delivery for tuberculosis: is inhaled therapy the key to success?
    Traini D; Young PM
    Ther Deliv; 2017 Oct; 8(10):819-821. PubMed ID: 28944739
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent patents and advances on anti - tuberculosis drug delivery and formulations.
    Vora C; Patadia R; Mittal K; Mashru R
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):138-49. PubMed ID: 23244680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
    Ahmad Z; Pandey R; Sharma S; Khuller GK
    Int J Antimicrob Agents; 2008 Feb; 31(2):142-6. PubMed ID: 18155883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
    Pandey R; Khuller GK
    Tuberculosis (Edinb); 2005 Jul; 85(4):227-34. PubMed ID: 15922668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice.
    Dutt M; Khuller GK
    Antimicrob Agents Chemother; 2001 Jan; 45(1):363-6. PubMed ID: 11121000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine and experimental tuberculosis: facts, flaws, and future.
    Pandey R; Ahmad Z
    Nanomedicine; 2011 Jun; 7(3):259-72. PubMed ID: 21329765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.
    Alves AD; Cavaco JS; Guerreiro F; Lourenço JP; Rosa da Costa AM; Grenha A
    Molecules; 2016 May; 21(6):. PubMed ID: 27240337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.